foxo4-dri mechanism of action Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment FOXO4-DRI: The Senolytic Peptide That

In moderate to severe TBI the signaling pathways become more complicated, and there are many potential pathways that can be targeted and blocked for therapeutic intervention like IL-6, TNFa, TLRs, S100 (DAMPs), RAGE, JAK2/STAT3, and/or VEGF/MET to prevent neuroglial overactivation, neuroinflammation, gliosis, loss of inhibition, synaptic knock-down, cell death, and chemokine secretion, and we hope to conduct further research on these conditions (2a)

I have experience in successfully treating patients with varying diagnoses in rehab, outpatient, acute, and home health settings

Sleep and recovery DSIP (Delta Sleep-Inducing Peptide) Studied for sleep architecture and stress response

I havent looked at a scale, but I definitely noticed my appetite dropped and my portions of food are way less